A recent study [44] found elevated levels of IL-2, IL-6, and interferon-gamma (IFN-γ) in patients suffering from co-morbid COPD and depression compared to healthy controls, though the implications of these findings remain uncertain. This evidence concerns the gene IFNG and depressive symptom measurement.